Preeclampsia is a severe complication of pregnancy, affecting 1 in 40 pregnant women. Identifying high-risk patients is often difficult and complex because the exact cause of preeclampsia is still unknown. Researchers from KU Leuven found that a DNA analysis can tell which women are at higher risk of preeclampsia in the later stages of pregnancy. By detecting high-risk patients early, preventive medication can be administered, dramatically reducing the risk of severe preeclampsia. The findings of this study were published today in Nature Medicine.
Preeclampsia is a serious condition that occurs in 1 in 40 pregnancies and is characterised by high blood pressure in the mother. ...
